Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area Sort ascending
Country
Application Due Date
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
Review Process: Pfizer Internal
Education Health Equity China
Optimizing maternal immunization practice and vaccination access during pregnancy in Italy
Release Date:
Review Process: Expert Review Panel
Quality Improvement Vaccines Italy
Develop Young Physicians to Lead the Increase in Preventive Awareness by Vaccination
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Vaccines Japan
RSV Infection and RSV Maternal Immunization in Area of Obstetrics and Gynecology
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Vaccines Japan
Sickle Cell Disease (SCD) Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Rare Disease Canada
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease USA
Increasing Awareness and Understanding of Amyloid Transthyretin Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Quality Improvement Grants to Improve Identification and Management of Patients with ATTR Amyloidosis
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease Spain
Junior Investigator Global ATTR Cardiac Amyloidosis Research
Release Date:
Review Process: Expert Review Panel
Research Rare Disease Australia, Canada, France, Germany, Italy, Japan, Korea, Spain
2024 Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Global Bridges at Mayo Clinic
Review Process: Expert Review Panel
Quality Improvement Rare Disease All
Title
Grant Type
Focus Area Sort ascending
Country
Application Due Date
Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Global Bridges at Mayo Clinic
Review Process: Expert Review Panel
Quality Improvement Rare Disease All
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Rare Disease Canada
Increasing Understanding of the Evolving Hemophilia Treatment Landscape
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease USA
Improving Knowledge and Capability to Communicate Information on the Latest Hemophilia Treatments
Release Date:
Review Process: Pfizer Internal
Education Rare Disease Japan
Establishing Regional Medical Care Coordination System for Detailed examination of the Causes of Heart Failure
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease Japan
Novel Digital Diagnostic Approaches in Acromegaly and Sickle Cell Disease
Release Date:
Review Process: Pfizer Internal
Research Rare Disease USA
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Rare Disease Canada
Global Awards for Research in DMD-AWARD
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
Release Date:
Review Process: Pfizer Internal
Research Rare Disease All
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA